Search results
Showing 3391 to 3405 of 8236 results
An approximate guide to the timings for the development of a piece of HealthTech guidance.
Our Medical Technologies Evaluation Programme (MTEP) considers technologies that could offer benefits to patients and the health and social care system over current practice.
Our Medical Technologies Evaluation Programme (MTEP) evaluates new HealthTech.
We want you to be involved in our work - whether you’re commenting on our draft recommendations, taking part in guidance development or attending a committee meeting, your voice is important to us.
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Day-to-day decision making is the responsibility of NICE's executive team.
Our board sets out our strategic priorities and policies. It has 2 sub-committees, the audit and risk assurance committee and the remuneration committee.
NICE helps practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
NICE's business plan, annual report, charter, transformation story, gender pay gap report, framework agreement and other publications.
The NICE board sets out our strategic priorities and policies.
Agenda and papers of the NICE public board meeting on 11 December 2024
Agenda and papers of the NICE public board meeting on 13 December 2023
Agenda and papers of the NICE public board meeting on 16 December 2022
Our board meetings are open to the public. You can download the agenda, papers and minutes for each meeting.